HCC Pharm ApS: Financial statements 2022
CVR: 41029013
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
HCC Pharm ApS (CVR 41029013) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 29,016 and a net result of DKK -13,489 compared with DKK -24,679 the year before. That is an increase of 57.9% compared with the year before. Equity in the 2022 report amounted to DKK -85,814. The company had 1 employee in the financial year.
- Gross Profit
- DKK 29,016
- Profit/Loss
- DKK -13,489
- Equity
- DKK -85,814
- Total Assets
- DKK 555,886
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 29K | -13K | -86K | 1 |
| 2021 | - | 18K | -25K | -72K | 1 |
| 2020 | - | -63K | -88K | -48K | 1 |
Official annual report
Keep an eye on HCC Pharm ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
HCC Pharm ApS has published its annual report for 2021. Gross profit came to DKK 18,381, and the net result was DKK -24,679.
About HCC Pharm ApS
HCC Pharm ApS is a Danish company of the type Anpartsselskab based in Haarby, founded in 2019. The company is registered under the industry Dyrkning af krydderiplanter, aromaplanter og lægeplanter. The management consists of Hartmuth Hermann Walter Kleiß. The company is owned by Hartmuth Hermann Walter Kleiß. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 21,630 and a net result of DKK -19,646 compared with DKK 21,488 the year before. Equity in the 2025 report amounted to DKK -88,244.